Deletion	O
of	O
the	O
Scl	O
+	O
19	O
enhancer	O
increases	O
the	O
blood	B-TISSUE
stem	I-TISSUE
cell	E-TISSUE
compartment	O
without	O
affecting	O
the	O
formation	O
of	O
mature	O
blood	B-TISSUE
lineages	E-TISSUE
.	O


The	O
stem	B-TISSUE
cell	E-TISSUE
leukemia	O
(	O
Scl	O
)	O
/	O
Tal1	O
gene	O
is	O
essential	O
for	O
normal	O
blood	S-TISSUE
and	O
endothelial	O
development	O
,	O
and	O
is	O
expressed	O
in	O
hematopoietic	B-TISSUE
stem	I-TISSUE
cells	E-TISSUE
(	O
HSCs	S-TISSUE
)	O
,	O
progenitors	O
,	O
erythroid	S-TISSUE
,	O
megakaryocytic	S-TISSUE
,	O
and	O
mast	B-TISSUE
cells	E-TISSUE
.	O


The	O
Scl	O
+	O
19	O
enhancer	O
is	O
active	O
in	O
HSCs	S-TISSUE
and	O
progenitor	O
cells	O
,	O
megakaryocytes	S-TISSUE
,	O
and	O
mast	B-TISSUE
cells	E-TISSUE
,	O
but	O
not	O
mature	O
erythroid	B-TISSUE
cells	E-TISSUE
.	O


Here	O
we	O
demonstrate	O
that	O
in	O
vivo	O
deletion	O
of	O
the	O
Scl	O
+	O
19	O
enhancer	O
(	O
Scl	O
(	O
Delta19	O
/	O
Delta19	O
)	O
)	O
results	O
in	O
viable	O
mice	O
with	O
normal	O
Scl	O
expression	O
in	O
mature	O
hematopoietic	B-TISSUE
lineages	E-TISSUE
.	O


By	O
contrast	O
,	O
Scl	O
expression	O
is	O
reduced	O
in	O
the	O
stem	O
/	O
progenitor	O
compartment	O
and	O
flow	O
cytometry	O
analysis	O
revealed	O
that	O
the	O
HSC	S-TISSUE
and	O
megakaryocyte	S-TISSUE
-	O
erythroid	B-TISSUE
progenitor	E-TISSUE
populations	O
are	O
enlarged	O
in	O
Scl	O
(	O
Delta19	O
/	O
Delta19	O
)	O
mice	O
.	O


The	O
increase	O
in	O
HSC	S-TISSUE
numbers	O
contributed	O
to	O
enhanced	O
expansion	O
in	O
bone	B-TISSUE
marrow	E-TISSUE
transplantation	O
assays	O
,	O
but	O
did	O
not	O
affect	O
multilineage	O
repopulation	O
or	O
stress	O
responses	O
.	O


These	O
results	O
affirm	O
that	O
the	O
Scl	O
+	O
19	O
enhancer	O
plays	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
hematopoietic	B-TISSUE
stem	I-TISSUE
/	I-TISSUE
progenitor	I-TISSUE
cells	E-TISSUE
,	O
but	O
is	O
not	O
necessary	O
for	O
mature	O
hematopoietic	B-TISSUE
lineages	E-TISSUE
.	O


Moreover	O
,	O
active	O
histone	O
marks	O
across	O
the	O
Scl	O
locus	O
were	O
significantly	O
reduced	O
in	O
Scl	O
(	O
Delta19	O
/	O
Delta19	O
)	O
fetal	O
liver	B-TISSUE
cells	E-TISSUE
without	O
major	O
changes	O
in	O
steady	O
-	O
state	O
messenger	O
RNA	O
levels	O
,	O
suggesting	O
post	O
-	O
transcriptional	O
compensation	O
for	O
loss	O
of	O
a	O
regulatory	O
element	O
,	O
a	O
result	O
that	O
might	O
be	O
widely	O
relevant	O
given	O
the	O
frequent	O
observation	O
of	O
mild	O
phenotypes	O
after	O
deletion	O
of	O
regulatory	O
elements	O
.	O
